About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
302 genotypes with 395 annotations displayed of selected term and subterms
Searched Term: increased liver tumor incidence
Allelic Composition
(Genetic Background)
Annotated Term Reference
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
increased hepatocellular carcinoma incidence J:21232
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
increased hepatocellular carcinoma incidence J:217802
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor)
increased hepatocellular carcinoma incidence J:217802
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N)
increased hepatocellular carcinoma incidence J:335836
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J)
increased hepatocellular carcinoma incidence J:174942
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J)
increased hepatocellular carcinoma incidence J:35794
increased hepatoma incidence J:48180
Acox2em1Jynz/Acox2em1Jynz
(involves: C57BL/6N)
increased liver tumor incidence J:323193
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
increased hepatoma incidence J:44690
increased liver adenoma incidence J:44690
Albtm1(cre/ERT2)Mtz/Alb+
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak

(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae)
increased hepatocellular carcinoma incidence J:254370
Altretm1.1Hbgl/Altretm1.1Hbgl
Foxp3tm4(YFP/icre)Ayr/Y

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
increased liver tumor incidence J:342907
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm)
increased liver tumor incidence J:221247
Anxa7tm1Pll/Anxa7+
(B6.Cg-Anxa7tm1Pll)
increased hepatocellular carcinoma incidence J:93685
ApcMin/Apctm1Tno
Ctnnb1tm4.1Wbm/Ctnnb1+

(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:156864
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:20443
Apctm1Tno/Apc+
(involves: 129 * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:156864
Apctm1Tno/Apctm1Tno
(involves: 129 * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:156864
Apctm2.1Cip/Apctm2.1Cip
(involves: 129P2/OlaHsd * C57BL/6N)
increased hepatocellular carcinoma incidence J:94721
Apctm2Rfo/Apc+
(B6.129P2-Apctm2Rfo)
increased liver tumor incidence J:151494
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1)
increased liver tumor incidence J:151494
Apctm2Rfo/Apc+
(129P2/OlaHsd-Apctm2Rfo)
increased liver tumor incidence J:151494
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd)
increased liver adenocarcinoma incidence J:176672
Atmtm1Awb/Atmtm1Awb
(A.129S6-Atmtm1Awb)
increased hepatocellular carcinoma incidence J:208539
Atp11cambr/Y
(C57BL/6-Atp11cambr)
increased hepatocellular carcinoma incidence J:171924
AurkaGt(XQ0149)Wtsi/Aurka+
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatoma incidence J:143099
Aurkbtm1.2Mama/Aurkb+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL)
increased liver adenocarcinoma incidence J:173575
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J)
increased hepatocellular carcinoma incidence J:86953
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:86982
Bhlha15tm2(Kras)Skz/Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6)
increased hepatocellular carcinoma incidence J:105076
increased liver adenoma incidence J:105076
Bhlha15tm2(Kras)Skz/Bhlha15+
Trp53tm1Tyj/Trp53+

(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
increased hepatocellular carcinoma incidence J:105076
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:177569
increased liver adenoma incidence J:177569
increased liver tumor incidence J:177569
Brca1tm2Cxd/Brca1tm2Cxd
Pkmtm1.1Mgvh/Pkmtm1.1Mgvh
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)4Mam/0

(involves: 129S4/SvJaeSor * 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)
increased liver tumor incidence J:205213
Brca1tm3Cxd/Brca1tm3Cxd
(involves: 129S6/SvEvTac * FVB/N)
increased hepatoma incidence J:94114
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
increased liver tumor incidence J:155810
Bub1tm1.1Tvd/Bub1tm1.1Tvd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
increased liver tumor incidence J:143035
Bub1tm2Jvd/Bub1tm2Jvd
(involves: 129/Sv * C57BL/6)
increased hepatocellular carcinoma incidence J:135093
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:201641
Catb/Catb
(C3.Cg-Catb/Anl)
increased hepatoma incidence J:154291
Cbx7tm1Afus/Cbx7+
(involves: C57BL/6J)
increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
Cbx7tm1Afus/Cbx7tm1Afus
(involves: C57BL/6J)
increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
increased liver tumor incidence J:184383
Ccdc80tm1.1Ftk/Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6N)
increased hepatocellular carcinoma incidence J:216704
Ccndbp1tm1Riet/Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:121623
increased liver adenoma incidence J:121623
Ccng1tm1Sst/Ccng1tm1Sst
(involves: 129S/SvEv * C57BL/6)
increased hepatoma incidence J:106007
Cdc20tm1.1Pzg/Cdc20+
(involves: 129S7/SvEvBrd * C57BL/6)
increased hepatoma incidence J:150421
Cdkn1atm1(HBsAg)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1(HBsAg)Xya/Cdkn1atm1(HBsAg)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Fahtm1Mgo/Fahtm1Mgo

(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
increased hepatocellular carcinoma incidence J:138701
Cdkn1atm2(HBx)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm2(HBx)Xya/Cdkn1atm2(HBx)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
increased hepatocellular carcinoma incidence J:88078
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
Nf2tm2Gth/Nf2tm2Gth

(involves: 129P2/OlaHsd * FVB/N)
increased liver tumor incidence J:131179
Cers2Gt(S16-4B1)Sor/Cers2Gt(S16-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
increased hepatocellular carcinoma incidence J:156841
increased liver tumor incidence J:156841
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0

(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
increased hepatocellular carcinoma incidence J:217463
increased liver adenoma incidence J:217463
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
Trp53tm1Gev/Trp53+

(B6.Cg-Trp53tm1Gev Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
increased hepatocellular carcinoma incidence J:217463
Col1a1tm1(tetO-URI1)Ndj/Col1a1tm1(tetO-URI1)Ndj
Tg(Cebpb-tTA)#Bjd/0

(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
increased hepatocellular carcinoma incidence J:217463
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * C57BL/6 * CBA)
increased hepatoblastoma incidence J:112659
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * C57BL/6 * CBA)
increased hepatoblastoma incidence J:112659
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
increased liver tumor incidence J:170976
Ddit3tm1.1Irt/Ddit3tm1.1Irt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(Mup3-Plau)350-2Eps/?

(involves: C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:233146
Dna2tm1.1Lzhg/Dna2+
(involves: 129S1/Sv)
increased hepatoma incidence J:198831
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J)
increased hepatocellular carcinoma incidence J:145228
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
increased hepatocellular carcinoma incidence J:163795
increased liver adenoma incidence J:163795
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6)
increased hepatocellular carcinoma incidence J:138701
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
increased hepatocellular carcinoma incidence J:27735
increased hepatoma incidence J:27735
increased liver adenoma incidence J:27735
increased liver tumor incidence J:27735
Fancmtm1.1Htr/Fancmtm1.1Htr
(involves: C57BL/6 * FVB)
increased hepatoma incidence J:151714
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
increased liver tumor incidence J:153501
Fbxo4tm1.1Jadi/Fbxo4+
(Not Specified)
increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified)
increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch)
increased hepatocellular carcinoma incidence J:244082
increased liver tumor incidence J:244082
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh
(involves: 129S1/Sv)
increased liver tumor incidence J:218627
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
increased liver tumor incidence J:231218
Fhittm1Tko/Fhittm1Tko
(involves: 129X1/SvJ)
increased hepatocellular carcinoma incidence J:93269
Foxa1tm1Khk/Foxa1tm1Khk
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Alb1-cre)1Khk/0

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
increased hepatocellular carcinoma incidence J:181296
Foxm1tm1Rhc/Foxm1tm1Rhc
(involves: 129X1/SvJ)
increased hepatocellular carcinoma incidence J:89472
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
increased hepatic hemangioma incidence J:118179
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Mx1-cre)1Cgn/0

(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
increased hepatic hemangioma incidence J:118179
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL)
increased liver tumor incidence J:137456
G6pc1tm1.1Ics/G6pc1tm1.1Ics
Albtm1(cre/ERT2)Mtz/Alb+

(involves: 129S2/SvPas * C57BL/6J)
increased liver adenoma incidence J:195257
Gfertm1.1Crg/Gfertm1.1Crg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:227242
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6)
increased hepatic hemangioma incidence J:146081
increased hepatocellular carcinoma incidence J:146081
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc3)12740Njen/0

(involves: C3H * C57BL/6J)
increased hepatocellular carcinoma incidence J:153656
increased liver adenoma incidence J:153656
increased liver tumor incidence J:153656
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0

(involves: C57BL/6 * DBA/2 * FVB/N)
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Trp53tm3Tyj/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0

(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
Gtf2ird1Tg(Alb1-Myc)166.8Sst/0
Tg(MtTGFA)42Lmb/0

(involves: C57BL/6 * CBA * CD-1)
increased hepatocellular carcinoma incidence J:4527
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
(involves: C57BL/6 * CBA)
increased hepatocellular carcinoma incidence J:34434, J:101128
increased liver adenoma incidence J:34434
increased liver tumor incidence J:101128
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
Tg(Alb-E2F1)8Sst/0

(involves: C57BL/6 * CBA)
increased hepatocellular carcinoma incidence J:101128
increased liver tumor incidence J:101128
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
Tg(MtTGFA)42Lmb/0

(involves: C57BL/6 * CBA * CD-1)
increased hepatocellular carcinoma incidence J:34434
increased liver adenoma incidence J:34434
H19tm1Tilg/H19+
Tg(CRP-TAg)60-3Urt/0

(involves: 129S/SvEv * BALB/c * C57BL/6 * SJL)
increased liver tumor incidence J:90036
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa)
increased liver tumor incidence J:296531
Hcif1C57BL/6J/Hcif1C57BR/cdJ
Hcif2C57BL/6J/Hcif2C57BR/cdJ

(involves: C57BL/6J * C57BR/cdJ)
increased hepatoma incidence J:33543
Hcif1C57BR/cdJ/?
(involves: C57BL/6J * C57BR/cdJ)
increased hepatoma incidence J:33543
Hcs1C3H/He/?
(involves: A/J * C3H/He)
increased hepatoma incidence J:3657
Hcs2C3H/He/?
(involves: A/J * C3H/He)
increased hepatoma incidence J:3657
Hcs3A/J/?
(involves: A/J * C3H/He)
increased hepatoma incidence J:3657
Hcs4C3H/He/Hcs4C57BL/6ByJ
(involves: C3H/He * C57BL/6JBy * M. spretus)
increased hepatoma incidence J:20738
Hcs5C3H/He/?
(involves: C3H/He * C57BL/6ByJ * M. spretus)
increased hepatoma incidence J:20738
Hcs6M. spretus/?
(involves: C3H/He * C57BL/6ByJ * M. spretus)
increased hepatoma incidence J:20738
Hcs7C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
increased hepatoma incidence J:31507
Hcs7C3H/HeJ/Hcs7C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
increased hepatoma incidence J:91132
Hcs7C3H/HeJ/Hcs7C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
increased hepatoma incidence J:91132
Hcs8CBA/J/Hcs8CBA/J
(involves: C57BL/6J * CBA/J)
increased hepatoma incidence J:91132
Hcs9C57BR/cdJ/Hcs9C57BR/cdJ
(B6.BR-(D1Mit5-D1Mit17))
increased hepatoma incidence J:91132
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:81448
Hif1atm3Rsjo/Hif1atm3Rsjo
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae

(involves: 129 * BALB/c * C57BL/6)
increased hepatic hemangioma incidence J:97652
Hip1tm4Tsr/Hip1+
Tg(Mx1-cre)1Cgn/0

(involves: 129X1/SvJ * C57BL/6 * CBA)
increased hepatocellular carcinoma incidence J:151974
increased liver tumor incidence J:151974
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae

(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
increased hepatic hemangioma incidence J:97652
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J)
increased hepatocellular carcinoma incidence J:87066
Htatip2tm1Hx/Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J)
increased hepatocellular carcinoma incidence J:87066
Ikbkgtm1.1Chtr/Y
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N * SJL)
increased hepatocellular carcinoma incidence J:151485
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N * SJL)
increased hepatocellular carcinoma incidence J:151485
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0

(involves: FVB/N)
increased hepatocellular carcinoma incidence J:160521
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N)
increased hepatocellular carcinoma incidence J:118336
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5+

(involves: 129S2/SvPas * C57BL/6)
increased hepatocellular carcinoma incidence J:207622
Iqgap1tm1Aber/Iqgap1tm1Aber
Iqgap2tm1Vs/Iqgap2tm1Vs

(involves: 129S4/SvJae)
increased hepatocellular carcinoma incidence J:132670
Iqgap2tm1Vs/Iqgap2tm1Vs
(either: 129S4/SvJae-Iqgap2tm1Vs or B6.129S4-Iqgap2tm1Vs)
increased hepatocellular carcinoma incidence J:132670
Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae)
increased hepatocellular carcinoma incidence J:205882
Krastm4Tyj/Kras+
Ptentm2Mak/Pten+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:254370
increased liver tumor incidence J:254370
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
increased liver tumor incidence J:254370
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S4/SvJae * C57BL/6 * DBA)
increased liver tumor incidence J:254370
Krastm4Tyj/Krastm4Tyj
Yap1tm1.1Dupa/Yap1tm1.1Dupa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:162628
Krt18tm1Tmm/Krt18+
(involves: 129P2/OlaHsd)
increased liver tumor incidence J:309021
Krt18tm1Tmm/Krt18tm1Tmm
(involves: 129P2/OlaHsd)
increased hepatocellular carcinoma incidence J:309021
increased liver tumor incidence J:309021
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Pklr-Myc)73Ak/0

(B6.Cg-Lect2tm1Ymg Tg(Pklr-Myc)73Ak)
increased hepatocellular carcinoma incidence J:184496
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1)
increased hepatocellular carcinoma incidence J:221030
Lzts1tm1Cro/Lzts1+
(involves: 129 * C57BL/6J)
increased hepatocellular carcinoma incidence J:119989
Lzts1tm1Cro/Lzts1tm1Cro
(involves: 129 * C57BL/6J)
increased hepatocellular carcinoma incidence J:119989
Mad1l1tm1.1Ktj/Mad1l1+
(involves: BALB/c * C57BL/6J)
increased hepatocellular carcinoma incidence J:117337
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0

(involves: 129P2/OlaHsd * FVB/N)
increased hepatocellular carcinoma incidence J:160521
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J)
increased hepatocellular carcinoma incidence J:177386
Mcm4chaos3/Mcm4chaos3
(C3.B6-Mcm4chaos3)
increased hepatocellular carcinoma incidence J:117494
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(AW0655)Wtsi
(involves: 129P2/OlaHsd * C3HeB/FeJ)
increased hepatocellular carcinoma incidence J:177420
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ)
increased hepatocellular carcinoma incidence J:177420
Mcm9Gt(XG743)Byg/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ)
increased hepatocellular carcinoma incidence J:177420
Mdm2tm3.1Glo/Mdm2tm3.1Glo
Trp53tm3.1Glo/Trp53+

(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo)
increased liver adenocarcinoma incidence J:164201
increased liver adenoma incidence J:164201
Mdm2tm4.1Glo/Mdm2tm4.1Glo
Trp53tm3.1Glo/Trp53+

(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo)
increased liver adenocarcinoma incidence J:164201
Mfsd1tm1a(KOMP)Wtsi/Mfsd1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
increased liver tumor incidence J:280713
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:190066
Mir122tm1.1Kgh/Mir122+
(involves: 129S1/Sv * 129X1/SvJ)
increased hepatocellular carcinoma incidence J:190067
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ)
increased hepatocellular carcinoma incidence J:190067
Mir122tm1.2Kgh/Mir122+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:190067
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:190067
increased liver tumor incidence J:190067
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn)
increased hepatocellular carcinoma incidence J:228499
increased liver adenoma incidence J:228499
Mob1atm1.2Asuz/Mob1atm1.2Asuz
Mob1bGt(CC0690)Wtsi/Mob1b+

(involves: 129P2/OlaHsd * C57BL/6)
increased liver tumor incidence J:193981
Msh2tm1Htr/Msh2+
(involves: 129P2/OlaHsd)
increased liver tumor incidence J:45433
Msh2tm1Rak/Msh2+
(involves: 129P2/OlaHsd)
increased liver adenoma incidence J:64667
Mzf1tm1Ppp/Mzf1tm1Ppp
(involves: 129)
increased hepatocellular carcinoma incidence J:70407
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+

(involves: C57BL/6 * C57BL/6NTac)
increased hepatocellular carcinoma incidence J:195140
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6)
increased liver adenocarcinoma incidence J:86563
increased liver adenoma incidence J:86563
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:207622
Ncoa5tm1Hxia/Ncoa5+
(C.129(B6)-Ncoa5tm1Hxia)
increased hepatocellular carcinoma incidence J:207622
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
increased hepatocellular carcinoma incidence J:210264
Ndrg2tm1Kmori/Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
increased hepatocellular carcinoma incidence J:210264
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6)
increased hepatoma incidence J:18542
Nf1tm1Tyj/Nf1+
Suz12Gt(Betageo)1Khe/Suz12+

(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
increased hepatocellular carcinoma incidence J:217077
Nf2tm2Gth/Nf2tm2Gth
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:162628
Nfe2l1tm1Jefc/Nfe2l1tm1Ywk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129X1/SvJ * C57BL/6J)
increased hepatocellular carcinoma incidence J:97188
increased liver adenoma incidence J:97188
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N)
increased hepatocellular carcinoma incidence J:121075
increased liver adenoma incidence J:121075
increased liver tumor incidence J:121075
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
increased hepatocellular carcinoma incidence J:118204
increased liver adenoma incidence J:118204
increased liver tumor incidence J:118204
Nsmce2Gt(AA0032)Wtsi/Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6)
increased liver tumor incidence J:227197
Nudt1tm1Tts/Nudt1tm1Tts
(involves: 129S/SvEv * C57BL/6 * DBA/2)
increased liver tumor incidence J:71836
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac)
increased liver adenoma incidence J:278655
Pex5tm1Pec/Pex5tm1Pec
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
increased liver tumor incidence J:112503
Pinx1tm1.1Kplu/Pinx1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
increased liver tumor incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53+

(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
increased hepatocellular carcinoma incidence J:171997
increased liver tumor incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53tm1Brd

(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
increased hepatocellular carcinoma incidence J:171997
increased liver tumor incidence J:171997
Plk3tm1Dai/Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6)
increased liver tumor incidence J:136425
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
increased liver adenoma incidence J:162378
Prdx1tm1Rave/Prdx1+
(involves: 129S6/SvEvTac * C57BL/6)
increased hepatocellular carcinoma incidence J:84677
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
increased hepatocellular carcinoma incidence J:84677
Prkar1atm1Gsm/Prkar1a+
(involves: 129X1/SvJ)
increased hepatocellular carcinoma incidence J:93393
Psmb9tm1Stl/Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:73945
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S4/SvJae * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:218587
increased liver tumor incidence J:218587
Ptentm1Hwu/Ptentm1Hwu
Tg(Alb1-cre)1Dlr/0

(involves: 129S4/SvJae * FVB/N)
increased hepatocellular carcinoma incidence J:111718
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J)
increased liver adenoma incidence J:53065
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:138099
increased liver adenoma incidence J:138099
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA)
increased hepatocellular carcinoma incidence J:90905
increased liver adenoma incidence J:90905
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre)1Dwi/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
increased hepatocellular carcinoma incidence J:143082
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
increased liver adenoma incidence J:172422
Rad50tm4.1Jpt/Rad50+
(involves: 129/Sv * C57BL/6)
increased hepatoblastoma incidence J:209141
increased liver adenoma incidence J:209141
increased liver tumor incidence J:209141
Rad50tm4Jpt/Rad50+
(involves: 129/Sv * C57BL/6)
increased liver adenoma incidence J:209141
increased liver tumor incidence J:209141
Rag1tm1Mom/Rag1tm1Mom
Trp53tm1Brd/Trp53tm1Brd

(involves: 129S7/SvEvBrd * C57BL)
increased hepatocellular carcinoma incidence J:141515
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0

(involves: 129S/SvEv * C57BL/6 * Swiss Webster)
increased hepatocellular carcinoma incidence J:235890
Ranbp2tm1Jvd/Ranbp2tm1.1Jvd
(involves: 129/Sv * C57BL/6)
increased hepatocellular carcinoma incidence J:137482
Ranbp2tm1Jvd/Ranbp2tm1Jvd
(involves: 129/Sv * C57BL/6)
increased hepatocellular carcinoma incidence J:137482
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Trp53tm1Tyj/Trp53tm1Tyj

(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl)
increased hepatocellular carcinoma incidence J:202603
increased liver tumor incidence J:202603
Rassf1tm1Gpp/Rassf1tm1Gpp
(involves: 129S1/SvImJ)
increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
Rassf1tm1Gpp/Rassf1tm1Gpp
Sav1tm1.1Gpp/Sav1+

(involves: 129S1/Sv * 129S1/SvImJ)
increased hepatoblastoma incidence J:231761
increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
increased hepatocellular carcinoma incidence J:168749
Rb1tm3Tyj/Rb1tm3Tyj
Rbl1tm1Tyj/Rbl1tm1Tyj
Rbl2tm2.1Tyj/Rbl2tm2.1Tyj

(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:177573
Rb1tm3Tyj/Rb1tm3Tyj
Tg(tetO-MYC)36aBop/0
Tg(Cebpb-tTA)5Bjd/0

(involves: FVB/N * NMRI)
increased hepatocellular carcinoma incidence J:172430
increased liver tumor incidence J:172430
Rbm38tm1.1Xch/Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N)
increased hepatoma incidence J:216929
Rcbtb2tm1.1Xyw/Rcbtb2+
(involves: C57BL/6 * CBA)
increased liver tumor incidence J:282928
Rcbtb2tm1.1Xyw/Rcbtb2tm1.1Xyw
(involves: C57BL/6 * CBA)
increased liver tumor incidence J:282928
Rint1tm1Whl/Rint1+
(Not Specified)
increased hepatocellular carcinoma incidence J:122805
Rr28tm1Tilg/Rr28+
Tg(CRP-TAg)60-3Urt/0

(involves: 129S1/Sv * C57BL/6 * SJL)
increased liver tumor incidence J:138826
S100a4tm1Amba/S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
increased hepatocellular carcinoma incidence J:89563
Sav1tm1.1Gpp/Sav1+
(involves: 129S1/Sv)
increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
Sav1tm1.1Rjo/Sav1tm1.1Rjo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL)
increased hepatocellular carcinoma incidence J:156531
Sav1tm1.1Rjo/Sav1tm1.1Rjo
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S6/SvEvTac * C57BL/6 * CBA * CD-1 * SJL)
increased liver tumor incidence J:156531
Sav1tm1.1Rjo/Sav1tm1.1Rjo
Tg(MMTV-cre)4Mam/0

(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL)
increased liver tumor incidence J:156531
Sav1tm1Dlim/Sav1+
(involves: 129S1/Sv * 129X1/SvJ)
increased hepatoma incidence J:160325
increased liver tumor incidence J:160325
Sav1tm1Dlim/Sav1tm1Dlim
(involves: 129S1/Sv * 129X1/SvJ)
increased liver tumor incidence J:160325
Sav1tm2.1Dlim/Sav1tm2.1Dlim
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:238319
increased hepatoma incidence J:160325
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss))
increased hepatocellular carcinoma incidence J:177486
Smurf2Gt(RRA098)Byg/Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:189320
Socs1tm1Jni/Socs1+
(Not Specified)
increased hepatoma incidence J:91651
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J)
increased hepatocellular carcinoma incidence J:219360
increased liver tumor incidence J:219360
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6)
increased hepatocellular carcinoma incidence J:132133
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac)
increased hepatocellular carcinoma incidence J:166879
increased liver tumor incidence J:166879
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased hepatoma incidence J:119999
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas)
increased hepatocellular carcinoma incidence J:184720
Stk3tm1.1Jav/Stk3+
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi

(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:153945
Stk3tm1.1Jav/Stk3tm1.1Jav
Stk4Gt(AJ0315)Wtsi/Stk4+

(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:153945
Stk3tm1.1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi

(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:153945
Stk3tm1.1Rjo/Stk3tm1.1Rjo
Stk4tm1.1Rjo/Stk4tm1.1Rjo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL)
increased hepatocellular carcinoma incidence J:156531
increased liver tumor incidence J:156531
Stk3tm1.1Yy/Stk3tm1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy

(involves: C57BL/6 * CBA)
increased liver tumor incidence J:156541
Stk3tm1.1Yy/Stk3tm1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy
Tg(CAG-cre/Esr1*)5Amc/0

(involves: C57BL/6 * CBA)
increased hepatocellular carcinoma incidence J:156541
increased liver tumor incidence J:156541
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi

(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:153945
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:153945
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * 129P2/OlaHsd * C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:238319
Stk11tm1Mmt/Stk11+
(involves: 129X1/SvJ)
increased hepatocellular carcinoma incidence J:76202
Stk11tm1Mmt/Stk11+
Trp53tm1Brd/Trp53tm1Brd

(involves: 129S7/SvEvBrd * 129X1/SvJ)
increased hepatocellular carcinoma incidence J:107275
increased liver tumor incidence J:107275
Stk11tm1Tpm/Stk11+
(Not Specified)
increased hepatocellular carcinoma incidence J:79074
increased liver adenoma incidence J:79074
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
Tg(Pklr-Myc)73Ak/0

(B6.Cg-Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak)
increased hepatocellular carcinoma incidence J:184496
Tg(ACTB-Eif4e)#Ppp/?
(Not Specified)
increased liver adenoma incidence J:89878
Tg(Alb1-Myc)#Sst/0
(involves: C57BL/6 * CBA)
increased hepatocellular carcinoma incidence J:34434
increased liver adenoma incidence J:34434
Tg(Alb1-Myc)#Sst/0
Tg(MtTGFA)42Lmb/0

(involves: C57BL/6 * CBA * CD-1)
increased hepatocellular carcinoma incidence J:34434
increased liver adenoma incidence J:34434
Tg(Alb1-Myc)#Sst/0
Tg(MtTGFA)Lmb/0

(involves: C57BL/6 * CBA * CD-1)
increased hepatocellular carcinoma incidence J:176432
Tg(Alb1HBV)43Bri/0
(involves: C57BL/6J)
increased liver tumor incidence J:86165
Tg(Alb1HBV)44Bri/0
(involves: C57BL/6J * SJL/J)
increased hepatocellular carcinoma incidence J:86165
increased liver adenoma incidence J:86165
increased liver tumor incidence J:86165
Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J)
increased hepatocellular carcinoma incidence J:223921
increased liver adenoma incidence J:223921
increased liver tumor incidence J:223921
Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6J * CBA/J)
increased hepatocellular carcinoma incidence J:65354, J:101128
increased liver adenoma incidence J:65354
increased liver tumor incidence J:65354, J:101128
Tg(Alb-HBx)A112Tfts/0
(involves: C57BL/6)
increased hepatocellular carcinoma incidence J:104728
Tg(Alb-HRAS*G12V)28Yu/0
(involves: C57BL/6J * CBA/J)
increased hepatocellular carcinoma incidence J:107083, J:238319
increased liver adenoma incidence J:107083, J:238319
increased liver tumor incidence J:107083, J:238319
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6)
increased hepatocellular carcinoma incidence J:96979, J:211984
Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA)
increased hepatocellular carcinoma incidence J:242582
Tg(Alb-TAg)1Gjh/0
(C3.Cg-Tg(Alb-TAg)1Gjh)
increased hepatocellular carcinoma incidence J:105110
Tg(Alb-TAg)#Arnd/0
(C3Fe.Cg-Tg(Alb-TAg)#Arnd)
increased hepatocellular carcinoma incidence J:171880
Tg(Amy1TAg)354Knw/0
(C57BL/6J-Tg(Amy1TAg)354Knw)
increased hepatoma incidence J:90326
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N)
increased liver tumor incidence J:158388
Tg(CD2-NPM/ALK)4Sudt/0
(involves: C57BL/6J * CBA)
increased liver tumor incidence J:181238
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0

(involves: C57BL/6 * Swiss Webster)
increased hepatocellular carcinoma incidence J:235890
Tg(Cebpb-tTA)5Bjd/0
Tg(tetO-MYC,-OVAL)#Gtgm/0

(B6J.Cg-Tg(Cebpb-tTA)5Bjd Tg(tetO-MYC,-OVAL)#Gtgm)
increased hepatocellular carcinoma incidence J:186226
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0

(involves: C57BL/6 * NMRI * SJL)
increased liver adenoma incidence J:94953
increased liver tumor incidence J:94953
Tg(Fabp1-Ccnd1)2Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)2Rdb)
increased liver adenoma incidence J:70394
Tg(Fabp1-Ccnd1)4Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)4Rdb/J)
increased hepatocellular carcinoma incidence J:70394
increased liver adenoma incidence J:70394
Tg(HBV-HCV)21Kko/0
(C57BL/6N-Tg(HBV-HCV)21Kko)
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
Tg(HBV-HCV)49Kko/0
(C57BL/6N-Tg(HBV-HCV)49Kko)
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
Tg(HBV-HCV)Kko/0
(C57BL/6N-Tg(HBV-HCV)Kko)
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
Tg(HBVX*,-Myc)#Skp/0
(Not Specified)
increased hepatocellular carcinoma incidence J:81098
Tg(HBVX*,-Myc)#Skp/Tg(HBVX*,-Myc)#Skp
(Not Specified)
increased hepatocellular carcinoma incidence J:81098
Tg(HBx)3Yu/0
(involves: C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:56196
Tg(Hnf1a-RB1*)XMiu/?
(Not Specified)
increased liver adenoma incidence J:180294
Tg(IRS1)1Mhep/0
Tg(SERPINA1-HBVX)1655Jtsb/0

(involves: C3H * C57BL/6 * FVB * ICR)
increased hepatocellular carcinoma incidence J:227278
Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA)
increased hepatoma incidence J:144382
Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA)
increased hepatoma incidence J:144382
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CD-1)
increased liver tumor incidence J:2578
Tg(MtTGFA)42Lmb/0
(involves: CD-1 * FVB/N)
increased liver tumor incidence J:2578
Tg(MtTGFA)42Lmb/Tg(MtTGFA)42Lmb
(involves: CD-1)
increased hepatocellular carcinoma incidence J:28452
Tg(Mup3-Plau)350-2Eps/0
(involves: C57BL/6)
increased liver tumor incidence J:66132
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps)
increased hepatocellular carcinoma incidence J:233146
increased liver adenoma incidence J:233146
increased liver tumor incidence J:233146
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
increased hepatocellular carcinoma incidence J:187236, J:77160
increased liver tumor incidence J:77160
Tg(Pklr-HRAS*G12V)23Ak/0
(involves: C57BL/6 * DBA/2)
increased hepatocellular carcinoma incidence J:44803
increased hepatoma incidence J:44803
Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:185488
increased hepatoma incidence J:185488
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tg(Pklr-Myc)73Ak)
increased hepatocellular carcinoma incidence J:184496
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:185488
increased hepatoma incidence J:185488
Tg(SERPINA1-TAg)1812Jtsb/0
(involves: C3H * C57BL/6 * ICR)
increased hepatocellular carcinoma incidence J:101633
Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2)
increased hepatocellular carcinoma incidence J:101541
Tg(SERPINC1-SV40)A1Pbr/Tg(SERPINC1-SV40)A1Pbr
(involves: C57BL/6 * DBA/2)
increased hepatocellular carcinoma incidence J:101541
X/Tg(SERPINC1-SV40)BPbr
(involves: C57BL/6 * DBA/2)
increased hepatocellular carcinoma incidence J:84204, J:101541
increased liver adenoma incidence J:84204
Tg(Tal1-cre/ERT)1Jrg/0
Tsc1tm1Djk/Tsc1tm1Djk

(involves: 129S4/SvJae * C57BL/6)
increased liver tumor incidence J:231316
Tg(tetO-MET)23Rwng/0
Tg(Cebpb-tTA)5Bjd/0

(involves: FVB/N * NMRI)
increased hepatocellular carcinoma incidence J:69731
Tg(tetO-MYC)36aBop/0
Tg(Cebpb-tTA)5Bjd/0

(involves: FVB/N * NMRI)
increased hepatoblastoma incidence J:93899
increased hepatocellular carcinoma incidence J:172430, J:186226, J:190067, J:93899
increased liver tumor incidence J:172430, J:93899
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53+

(involves: 129S2/SvPas * C57BL/6)
increased liver adenocarcinoma incidence J:72391
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6)
increased hepatocellular carcinoma incidence J:140639
increased hepatoma incidence J:140639
Tnk1tm1Sksuf/Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6)
increased hepatocellular carcinoma incidence J:140639
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J)
increased hepatocellular carcinoma incidence J:184948
Trim24tm1.1Los/Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL)
increased hepatocellular carcinoma incidence J:130210
increased liver adenoma incidence J:130210
increased liver tumor incidence J:130210
Trim62tm1Akil/Trim62+
(involves: 129S/SvEv * C57BL/6)
increased hepatocellular carcinoma incidence J:204336
increased liver adenocarcinoma incidence J:204336
Trim62tm1Akil/Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6)
increased liver adenocarcinoma incidence J:204336
Trp53tm1.1Xlu/Trp53tm1.1Xlu
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * FVB/N)
increased liver tumor incidence J:166152
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+

(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:98958
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae)
increased hepatocellular carcinoma incidence J:95316
Tsc1tm1.1Djk/Tsc1+
(either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J))
increased hepatic hemangioma incidence J:75243
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * C57BL/6JOlaHsd)
increased hepatic hemangioma incidence J:99796
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * Balb/cOlaHsd * C57BL/6JOlaHsd)
increased hepatic hemangioma incidence J:99796
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * C3H/HeNHsd * C57BL/6JOlaHsd)
increased hepatic hemangioma incidence J:99796
Tsc1tm1Hin/Tsc1+
(involves: 129S4/SvJae * C57BL/6J)
increased hepatic hemangioma incidence J:70463
Tsc2tm1Djk/Tsc2+
(either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J))
increased hepatic hemangioma incidence J:57631
Tsc2tm1Tno/Tsc2+
(involves: 129S4/SvJae * C57BL/6J)
increased hepatic hemangioma incidence J:52464
Tspan33tm1Stsa/Tspan33tm1Stsa
(involves: 129S1/Sv * 129X1/SvJ)
increased liver tumor incidence J:143158
TxnipHyplip1/Txnip+
(involves: CAST/Ei * HcB19/Dem)
increased hepatocellular carcinoma incidence J:112292
TxnipHyplip1/TxnipHyplip1
(HcB19/Dem-TxnipHyplip1)
increased hepatocellular carcinoma incidence J:112292
TxnipHyplip1/TxnipHyplip1
(involves: CAST/Ei * HcB19/Dem)
increased hepatocellular carcinoma incidence J:112292
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy)
increased hepatocellular carcinoma incidence J:157049
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
increased hepatocellular carcinoma incidence J:164423
Usp24Gt(XB614)Byg/Usp24+
(involves: 129P2/OlaHsd * C57BL/6)
increased liver tumor incidence J:303991
Usp44tm1.2Pjgl/Usp44tm1.2Pjgl
(involves: 129S4/SvJae * 129S7/SvEvBrd)
increased hepatoma incidence J:193965
Vhltm1.1Jae/Vhl+
(involves: 129S4/SvJae * BALB/c)
increased hepatic hemangioma incidence J:67505
Vhltm1.1Lss/Vhl+
(involves: BALB/c)
increased hepatic hemangioma incidence J:85513
Vhltm1Lss/Vhltm1.1Lss
(involves: 129X1/SvJ * C57BL/6)
increased hepatic hemangioma incidence J:85513
Vhltm1Lss/Vhltm1.1Lss
Tg(ACTB-cre)1Tes/0

(involves: 129X1/SvJ * C3H * C57BL/6)
increased hepatic hemangioma incidence J:85513
Wwc1tm1Arsc/Wwc1tm1Arsc
Wwc2tm1.1Arte/Wwc2tm1.1Arte
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * C57BL/6 * C57BL/6J * DBA)
increased liver tumor incidence J:305034
Xpatm1Tnka/Xpatm1Tnka
(C3.Cg-Xpatm1Tnka)
increased liver adenoma incidence J:76206
increased liver tumor incidence J:76206

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory